Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 1/2 3 Phase 4 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 91 Neoplasms 75 Prostatic Neoplasms 54 Carcinoma, Hepatocellular 53 Colorectal Neoplasms 49 Leukemia, Myeloid, Acute 41 Stomach Neoplasms 36 Carcinoma, Non-Small-Cell Lung 36 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Neoplasm Metastasis 29 Pancreatic Neoplasms 27 Lung Neoplasms 26 Rectal Neoplasms 23 Multiple Myeloma 21 Hematologic Neoplasms 21 Head and Neck Neoplasms 20 Colonic Neoplasms 20 Recurrence 19 Lymphoma 19 Leukemia 19 Polycystic Ovary Syndrome 16 Liver Neoplasms 14 Esophageal Neoplasms 14 Brain Neoplasms 13 Myelodysplastic Syndromes 12 Melanoma 12 Endometrial Neoplasms 12 Uterine Cervical Neoplasms 11 Motor Activity 11 Fatigue 11

Interventions

penclomedine 1 Exenatide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER × Fatty Liver × Clear all

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡